Turtle Cameron 4
4 · Spyre Therapeutics, Inc. · Filed Jan 13, 2026
Insider Transaction Report
Form 4
Turtle Cameron
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-01-09+528,000→ 528,000 totalExercise: $30.61Exp: 2036-01-09→ Common Stock (528,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 528,000 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact|2026-01-13